S
IONS icon

Sachetta’s Ionis Pharmaceuticals IONS Stock Holding History

Sachetta’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73K Buy
47
+2
+4% +$151 ﹤0.01% 731
2026
Q1 		$3.38K Hold
45
– – ﹤0.01% 775
2025
Q4 		$3.56K Hold
45
– – ﹤0.01% 631
2025
Q3 		$2.94K Hold
45
– – ﹤0.01% 727
2025
Q2 		$1.78K Buy
45
+29
+181% +$949 ﹤0.01% 835
2025
Q1 		$483 Sell
16
-11
-41% -$360 ﹤0.01% 1044
2024
Q4 		$944 Sell
27
-71
-72% -$2.65K ﹤0.01% 1004
2024
Q3 		$3.93K Hold
98
– – ﹤0.01% 689
2024
Q2 		$4.88K Sell
98
-17
-15% -$697 ﹤0.01% 596
2024
Q1 		$5.82K Hold
115
– – ﹤0.01% 496
2023
Q4 		$5.82K Buy
+115
New +$5.51K ﹤0.01% 496

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sachetta's IONS Position: Q2 2026 in Review

Sachetta increased its Ionis Pharmaceuticals (IONS) stake by 4.4% in Q2 2026, buying an estimated $151 and bringing the position to 47 shares worth $3.73K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Sachetta first reported a position in IONS in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.82K in Q1 2024. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Sachetta held 47 shares of Ionis Pharmaceuticals worth $3.73K as of Q2 2026.
  • Sachetta bought 2 Ionis Pharmaceuticals shares in Q2 2026, an estimated $151.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #731 holding.
  • Sachetta first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Ionis Pharmaceuticals position peaked at $5.82K in Q1 2024.
  • 513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.